Advertisement
Advertisement
U.S. markets close in 4 hours 30 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Opsens Inc. (OPSSF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.9900-0.0250 (-1.24%)
As of 09:35AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.0150
Open1.9900
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.9900 - 1.9900
52 Week Range1.2000 - 2.9900
Volume100
Avg. Volume23,448
Market Cap216.564M
Beta (5Y Monthly)0.62
PE Ratio (TTM)N/A
EPS (TTM)-0.0460
Earnings DateJul 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for OPSSF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • OPSENS INC
    Daily – Vickers Top Buyers & Sellers for 05/09/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    3 months agoArgus Research
View more
  • CNW Group

    OPSENS ANNOUNCES THIRD QUARTER FISCAL 2022 FINANCIAL RESULTS WITH RECORD QUARTERLY REVENUES

    OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today released results for its third quarter ended May 31, 2022.

  • CNW Group

    OpSens Awarded Interventional Specialty Diagnostics Agreement with Premier for OptoWire III

    OpSens Inc.. ("OpSens" or the "Company") (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology has been awarded a national group purchasing agreement for Interventional Specialty Diagnostics with Premier, Inc. (Premier), a leading healthcare improvement company uniting an alliance with approximately 4,400 U.S. hospitals and health systems. Effective July 1st, the new agreement allows Premier members, at th

  • CNW Group

    OPSENS TO HOST THIRD QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY, JULY 14

    OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, will report financial results for its third quarter of fiscal year 2022, ended May 31st, on Thursday, July 14, before the open of the market. The Company has scheduled a conference call the same day, at 11:00 AM ET, to review the results.

Advertisement
Advertisement